Canton Strategic Holdings (CNTN) Total Current Liabilities (2020 - 2026)
Canton Strategic Holdings (CNTN) posted Total Current Liabilities of $1.1 million for Q1 2026, down 65.27% on a QoQ basis from $3.3 million in Q4 2025, and down 53.9% year-over-year from $2.5 million in Q1 2025.
Canton Strategic Holdings (CNTN) Total Current Liabilities (2020 - 2026) Analysis & Trends
Canton Strategic Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- Quarterly Total Current Liabilities fell 53.9% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 53.9% YoY) and the FY2025 annual result came in at $3.3 million, up 36.14% from the prior year.
- Total Current Liabilities was $1.1 million for Q1 2026 at Canton Strategic Holdings, down from $3.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $3.3 million in Q4 2025 and bottomed at $902348.0 in Q3 2022.
- A 5-year average of $1.8 million and a median of $1.6 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities sank 74.75% — and 2023, when it soared 58.52%.
- Canton Strategic Holdings' Total Current Liabilities stood at $1.1 million in 2022, then surged by 58.52% to $1.8 million in 2023, then jumped by 33.0% to $2.4 million in 2024, then surged by 36.14% to $3.3 million in 2025, then slumped by 65.27% to $1.1 million in 2026.
- Business Quant data shows CNTN's Total Current Liabilities at $1.1 million in Q1 2026, $3.3 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 2.48 Mn |
| Dec 31, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 1.82 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 902,348.00 |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 4.53 Mn |
| Dec 31, 2020 | 2.73 Mn |